Latest Breaking News On - Diakonos oncology - Page 1 : comparemela.com

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma | Region

HOUSTON (BUSINESS WIRE) Apr 9, 2024

United statesMike wicksJay hartenbachDiakonos oncology corpAmerican association for cancer researchOncology corpCancer researchFast trackOrphan drugDiakonos oncologyBusiness wire

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma

Diakonos Oncology s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMike wicksDiakonos oncology corpAmerican association for cancer researchCancer researchOncology corpFast trackOrphan drugDiakonos oncology

Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma

Dendritic Cell Vaccine Improves Survival Compared to Standard of Care in Phase I Trial for Glioblastoma
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoMike wicksAmerican association for cancer research annual meetingDiakonos oncologyAmerican associationCancer research annual meetingFast trackOrphan drug

Diakonos Oncology Names Paul Lammers, M D , Veteran BioPharma Senior Executive, to its Board of Directors

Diakonos Oncology Names Paul Lammers, M D , Veteran BioPharma Senior Executive, to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBaylor college of medicinePaul lammersAnderson cooperTriumvira immunologicsMike wicksUs product developmentDiakonos oncology corpChief executive officerMirna therapeuticsChief medical officerDiakonos oncologyBaylor college

Diakonos Oncology Names Ian H Bellayr, Ph D Chief Regulatory Officer

HOUSTON (BUSINESS WIRE) Nov 20, 2023

United statesIanh bellayrJay hartenbachMike wicksDiakonos oncology corporationNational institutes of healthBiotechnology branchDivision of cellularDrug administrationNational institute of diabetesUniversity of virginiaUniversity of pittsburghNational institute of allergyDiakonos oncology corpOncology corporationNational institutes